Furthermore, MET suppresses the overexpression of vascular endothelial growth factor (VEGF), which plays a pivotal role in pathological neovascularization and macular edema in diabetic retinopathy (DR) [59]. This evidence concerns the gene VEGFA and macular retinal edema.